☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
CALAVI Study
AstraZeneca Reports Results of Calquence (acalabrutinib) in CALAVI Study for Hospitalized COVID-19 Patients
June 8, 2020
AstraZeneca Initiates CALAVI Study Evaluating Calquence (acalabrutinib) Against COVID-19
April 15, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
